Skip to content

Clinical Study on the Therapeutic Efficacy of Bloodletting at the Twelve Hand Jing-Well Points in Patients with Cerebral Edema Following Intracerebral Hemorrhage (ICH)

Clinical Study on the Therapeutic Efficacy of Bloodletting at the Twelve Hand Jing-Well Points in Patients with Cerebral Edema Following Intracerebral Hemorrhage (ICH)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000963
Enrollment
Unknown
Registered
2025-05-13
Start date
2025-03-25
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage

Interventions

Intervention Group:Basic treatment+bloodletting at the twelve Jing-well points of the hand
Control group:Basic treatment

Sponsors

Zhejiang Provincial People's Hospital Bijie Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Meeting the diagnostic criteria for intracerebral hemorrhage (ICH) as defined in the Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage (2014) confirmed by cranial CT or MRI imaging. Patients within 14 days of symptom onset with concurrent cerebral edema and limb dysfunction. No more than 2 prior episodes of ICH. Presence of a unilateral cerebral lesion. Aged between 18 and 85 years. Provision of written informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Patients with unstable vital signs. Contraindications for acupuncture or bloodletting therapy due to local trauma surgical history or severe dermatological conditions at the treatment sites. Inability to cooperate with scale assessments caused by impaired consciousness language comprehension deficits attention disorders or cognitive impairments. Comorbidities including intracranial space-occupying lesions malignant tumors uncontrolled epilepsy severe infections psychiatric disorders coagulation abnormalities or other severe uncontrolled systemic diseases.

Design outcomes

Primary

MeasureTime frame
Cerebral edema volume;

Secondary

MeasureTime frame
Barthel Index;Modified Rankin Scale;National Institutes of Health Stroke Scale;Shortened Fugl-Meyer Assessment;Brunnstrom Stages;Traditional Chinese Medicine (TCM) Syndrome Score;

Countries

China

Contacts

Public ContactYan Gao

Zhejiang Provincial People's Hospital Bijie Hospital

1710552362@qq.com13124604014

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026